Sleep quality of mechanically ventilated patients sedated with dexmedetomidine
- 1.7k Downloads
Dexmedetomidine is thought to activate an endogenous pathway that naturally promotes non-rapid eye movement (NREM) sleep. Dexmedetomidine may induce restorative sleep, that is, NREM stage 3 and 4 (slow wave sleep; SWS) or sleep continuity in mechanically ventilated patients. Few data have been published, however, on the sleep characteristics of mechanically ventilated patients during dexmedetomidine infusion.
We recorded polysomnography (PSG) for 24 h in mechanically ventilated patients sedated with dexmedetomidine. Dexmedetomidine (0.2–0.7 μg/kg/h) was administered intravenously to maintain the Richmond Agitation–Sedation Scale between −1 and −4 only during the nighttime (9:00 p.m. to 6:00 a.m.). During the daytime, we interrupted the sedatives and analgesics unless the patient complained of discomfort. When this occurred midazolam or opioids were administered intermittently. Sleep stages and the frequency of arousal/awakening during the nighttime were analyzed using Rechtschaffen and Kales criteria.
For the ten mechanically ventilated adult patients recruited into the study, the median total sleep time (TST) during the night was 4.7 h (IQR, 4.2–8.1 h), and 78 % of sleep occurred during the night (median 78 %, IQR: 69–88 %). Sleep architecture was exclusively NREM sleep stage 1 (median 28.9 % of TST) and stage 2 (median 71.2 % of TST). Neither SWS (median 0 % of TST) nor rapid eye movement (REM) sleep (median 0 % of TST) was observed. Median frequency of arousals/awakenings was 9.3/h (IQR, 3–19.5/h).
In mechanically ventilated patients, nighttime infusion of dexmedetomidine preserved the day-night cycle of sleep but induced severely disturbed sleep architecture without evidence of SWS or REM sleep.
KeywordsDexmedetomidine Sleep stage Mechanical ventilation Sedation
This study was supported by departmental funding.
Conflicts of interest
- 6.Roche Campo F, Drouot X, Thille AW, Galia F, Cabello B, d’Ortho MP, Brochard L (2010) Poor sleep quality is associated with late noninvasive ventilation failure in patients with acute hypercapnic respiratory failure. Crit Care Med 38:477–485. doi: 10.1097/CCM.0b013e3181bc8243 PubMedCrossRefGoogle Scholar
- 14.Oto J, Yamamoto K, Koike S, Imanaka H, Nishimura M (2011) Effects of daily sedative interruption on sleep stages of mechanically ventilated patients receiving midazolam by infusion. Anesth Intensive Care 39:392–400Google Scholar
- 17.Pandharipande PP, Pun BT, Herr DL, Maze M, Girard TD, Miller RR, Shintani AK, Thompson JL, Jackson JC, Deppen SA, Stiles RA, Dittus RS, Bernard GR, Ely EW (2007) Effect of sedation with dexmedetomidine vs. lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA 298:2644–2653. doi: 10.1001/jama.298.22.2644 PubMedCrossRefGoogle Scholar
- 18.Riker RR, Shehabi Y, Bokesch PM, Ceraso D, Wisemandle W, Koura F, Whitten P, Margolis BD, Byrne DW, Ely EW, Rocha MG, SEDCOM (Safety and Efficacy of Dexmedetomidine Compared With Midazolam) Study Group (2009) Dexmedetomidine vs. midazolam for sedation of critically ill patients: a randomized trial. JAMA 301:489–499. doi: 10.1001/jama.2009.56 PubMedCrossRefGoogle Scholar
- 21.Rechtschaffen A, Kales A (1968) A manual of standardized terminology: techniques and scoring system for sleep stages of human subjects. Brain Research Institute, UCLA, Los Angeles National Institute of Health publication 2040Google Scholar
- 31.Venn RM, Newman PJ, Grounds RM (2003) A phase II study to evaluate the efficacy of dexmedetomidine for sedation in the medical intensive care unit Intensive Care Med 29:201–207Google Scholar